Observational studyAmerican heart journal2022

Prevalent pharmacotherapy of US Fontan survivors: A study utilizing data from the MarketScan Commercial and Medicaid claims databases.

Michael L O'Byrne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.